Notably, the genetic background could act as a strong modifier of the pro-tumor effect of PPARγ, as examplified by the predisposition of certain PPARγ polymorphisms (i.e., Pro12Ala and C161T) to breast cancer [41]. The gene discussed is PPARG; the disease is breast carcinoma.